
About Bioliberty is on a mission to give everyone the best chance at recovery from a mobility-limiting condition or injury so they can regain their independence. Founded in 2020, we've raised $17.5 million from a mix of public and private investors and launched our first product to the U.S. healthcare market in May 2025. We hold seven patents across our core technologies, Lifehub and Lifeglov - both of which are FDA-registered. We’re now entering an exciting new phase of growth and are seeking a